Healius Limited
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patie… Read more
Healius Limited (PHCRF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2019: 0.018x
Based on the latest financial reports, Healius Limited (PHCRF) has a cash flow conversion efficiency ratio of 0.018x as of June 2019.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($36.00 Million) by net assets ($2.06 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Healius Limited - Cash Flow Conversion Efficiency Trend (2016–2020)
This chart illustrates how Healius Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Healius Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Healius Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CGG SA
LSE:0RI9
|
0.051x |
|
Jinneng Science&Tech Co Ltd
SHG:603113
|
-0.044x |
|
Kimball Electronics
NASDAQ:KE
|
0.012x |
|
Verve Group SE
PINK:MGIMF
|
0.011x |
|
Hubei Heyuan Gas Co Ltd
SHE:002971
|
0.087x |
|
Metropole Tv
OTCGREY:MTPVY
|
0.048x |
|
Yunnan Nantian Electronics Information Co Ltd
SHE:000948
|
-0.005x |
|
Tianneng Power International Limited
PINK:TIANF
|
0.046x |
Annual Cash Flow Conversion Efficiency for Healius Limited (2016–2020)
The table below shows the annual cash flow conversion efficiency of Healius Limited from 2016 to 2020.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2020-06-30 | $1.93 Billion | $339.20 Million | 0.176x | +182.91% |
| 2019-06-30 | $2.06 Billion | $127.60 Million | 0.062x | -44.16% |
| 2018-06-30 | $1.82 Billion | $202.20 Million | 0.111x | -2.08% |
| 2017-06-30 | $1.87 Billion | $212.20 Million | 0.114x | -3.33% |
| 2016-06-30 | $2.43 Billion | $285.10 Million | 0.117x | -- |